HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 135.50
-2.50 (-1.81%)
At close: Oct 30, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 18.97 billion as of October 30, 2026. It is the 13,201st most valuable company in the world and the 434th biggest in Taiwan. Its market cap has increased by 116.86% in one year.
Market Cap
18.97B
Enterprise Value
17.49B
Revenue
321.77M
Global Rank
Country Rank
#434 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 18.97B, an increase of 243.59%. That is a compound annual growth rate of 147.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 18.97B | 64.74% |
| Dec 31, 2025 | 11.51B | 108.56% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 50.09B |
| A-Top Health Biotech | 25.31B |
| Elixiron Immunotherapeutics (Cayman) Limited | 15.71B |
| Intelligene | 8.15B |
| Obigen Pharma | 7.24B |
| Uwell Biopharma | 5.83B |
| Tripartite Therapeutics | 4.69B |
| Pet Pharm Biotech | 2.96B |